Partner
- christina.takke@forbion.com
- Download vCard 
Christina Takke is Partner at Forbion Capital Partners and joined the team at ABN AMRO Capital Life Sciences as analyst in 2000.
Before that Christina worked with Bio-Gen-Tec-NRW in Cologne, Germany, a regional development organization for the biotechnology industry. Here she evaluated business proposals and assisted companies in the fundraising process.
At Forbion Christina is responsible for scouting and analysis of new investment opportunities as well as the general deal execution.
Christina serves on the Supervisory Boards of arGEN-X and Pieris.Previously, she was on the board of Bioceros and was closely involved with GlycArt (sold to Roche in 2005) as Observer.
Christina began her scientific career with a master’s degree in biology from the Technical University of Darmstadt. She subsequently joined the group of Prof Dr, Campos-Ortega at the Institute of Development Biology of the University of Cologne, where she studied the Delta-Notch signaling pathway and its role during zebra fish neurogenesis and early somite development.
